PCM
CLVS

Peregrine Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Peregrine Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-143,613
Closed -$11.8M – 254
2017
Q3 		$11.8M Buy
143,613
+17,443
+14% +$1.44M 0.28% 142
2017
Q2 		$11.8M Buy
+126,170
New +$11.8M 0.29% 142